Allergen immunotherapy for allergic asthma

Virchow, J. Christian; Pfaar, Oliver; Lommatzsch, Marek

Allergen immunotherapy for allergic asthma

Document detail

ID

oai:pubmedcentral.nih.gov:1079...

Topic

Reviewh Article

Author

Virchow, J. Christian Pfaar, Oliver Lommatzsch, Marek

Langue

Editor

Dustri-Verlag Dr. Karl Feistle

Year

2024

listing date

2/9/2024

Keywords

patients

Metrics

Abstract

Remission is the goal of modern asthma treatment.

Allergen immunotherapy (AIT) is an essential component in the armamentarium of personalized asthma therapy.

Subcutaneous AIT (SCIT) or sublingual AIT (SLIT) offer the possibility to prevent asthma in patients with allergic rhinitis (reduction of the risk of developing asthma) and the possibility to achieve remission in patients with allergic asthma.

Accordingly, AIT should always be considered in patients with asthma and a documented, clinically relevant allergy.

However, precise phenotyping of the patient is an essential prerequisite for a success of AIT in asthma.

Virchow, J. Christian,Pfaar, Oliver,Lommatzsch, Marek, 2024, Allergen immunotherapy for allergic asthma , Dustri-Verlag Dr. Karl Feistle

Document

Open Open

Source